The degrees of infiltration of CD4+ and CD8+ T cells in the tumors of immunocompetent mice were examined and indicated that the number of tumor-infiltrating CD8+ T cells was markedly increased after treatment with the TBK1 antagonist (Figure 7H). The gene discussed is CD4; the disease is neoplasm.